1Ruckdeschel JC,Finkelstein DM,Ettinger DS. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer[J].Journal of Clinical Oncology,1986.14-22.
2Bonomi P,Kim K,Fairclough D. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin:results of anEastern Cooperative Oncology Group trial[J].Journal of Clinical Oncology,2000.623-631.
3Ramsey SD,Moinpour CM,Lovato LC. Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer[J].Journal of the National Cancer Institute,2002.291-297.
4Fisher MD,D'Orazio A. Phase Ⅱ and Ⅲ trials:comparison of four chemotherapy regimens in advanced non small-cell lung cancer(ECOG 1594)[J].Clinical Lung Cancer,2000.21-22.
5Chemotherapy in non-small cell lung cancer a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group[J].British Medical Journal,1995.899-909.
6Delbaldo C,Michiels S,Syz N. Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer:a meta-analysis[J].Journal of the American Medical Association,2004.470-484.
7Schiller JH,Harrington D,Belani CP. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J].New England Journal of Medicine,2002.92-98.
8Jett JR,Schild SE,Keith RL. Treatment of nonsmall cell lung cancer,stage ⅢB:ACCP evidence-based clinical practice guidelines(2nd edition)[J].Chest,2007.266S-276S.
9Kelly K,Crowley J,Bunn PA. Randomized phase Ⅲ trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer:a Southwest Oncology Group trial[J].Journal of Clinical Oncology,2001.3210-3218.
10Hu L,Liang G,Yuliang W. Assessing the effectiveness and safety of liposomal paclitaxel in combination with cisplatin as first-line chemotherapy for patients with advanced NSCLC with regional lymph-node metastasis:study protocol for a randomized controlled trial(PLC-GC trial)[J].Trials,2013.45.
